Other languages Isofol Medical AB

Equities

Delayed Nasdaq Stockholm Other stock markets 11:16:05 2024-04-29 am EDT			5-day change	1st Jan Change
0.74 ^SEK	+6.63%		+2.92%	+1.37%

Feb. 20	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 20	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20
Isofol Medical Hires New CFO	Jan. 11
Isofol Medical Names New CEO	Jan. 09
Isofol Medical AB Announces CEO Changes	Jan. 09
Isofol Medical AB Announces Board Elections	Jan. 04
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	Dec. 28
Isofol Medical AB Appoints Jan-Eric Österlund as Member of the Board	Dec. 13
Isofol Receives the First Results from Laboratory Tests of Arfolitixorin	Dec. 07
Isofol Medical Unit to Face Liquidation	Dec. 01
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10
Isofol Receives Shareholders Request for EGM; Shares Fall	Nov. 09
Isofol Medical AB Announces Appointment of Nomination Committee Members	Nov. 08
Isofol Medical AB Announces Results from the Modelle 001 Study	23-10-05
Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22
Isofol Medical AB Presents Conclusions from the In-Depth Analysis of the AGENT Study	23-07-04
Sweden's Isofol Medical Names Acting CEO	23-06-23
Isofol Medical AB Appoints Roger Tell as Acting CEO	23-06-22
Isofol Medical CEO Steps Down	23-06-22
Isofol Medical AB Announces Resignation of Thomas Andersson as CEO	23-06-21

No results for this search